Pages

▼
Wednesday, September 02, 2020

Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End? (rerun)

›
This week, I’m rerunning some popular posts while I work on the forthcoming 2020-21 Economic Report on Pharmaceutical Wholesalers and Specia...
Tuesday, September 01, 2020

PBMs and Drug Spending in 2019: CVS Health and Express Scripts Outperform Prime Therapeutics (rerun)

›
This week, I’m rerunning some popular posts while I work on the forthcoming 2020-21 Economic Report on Pharmaceutical Wholesalers and Spec...
Monday, August 31, 2020

How GoodRx Profits from Our Broken Pharmacy Pricing System

›
On Friday, GoodRx filed its Form S-1 in preparation for going public. Link below. The company is insanely profitable. Its adjusted net i...
Friday, August 28, 2020

The ConnectiveRx Non-Commercial Pharmacy: Maximize Your Patient Access Strategy

›
Today’s guest post comes from Frank Dana, Chief Commercial Officer at ConnectiveRx. Frank discusses the access challenges that patients ...
Wednesday, August 26, 2020

Five Surprising Facts About COVID-19 Prescription Trends for Retail and Mail Pharmacies

›
Somehow, we are nearly two-thirds of the way through 2020. It’s time to explore what’s been happening within the U.S. prescription market ...
Friday, August 21, 2020

Improve Compliance and Create Transparency with 340B Rebates (Free webinar)

›
As regular readers know, I believe the 340B Drug Pricing Program needs to evolve into a more transparent, properly regulated program. That...
Tuesday, August 18, 2020

Hospitals Continue Their Startling Expansion into Specialty Pharmacy

›
Hospitals and health systems are building a major presence in the specialty pharmacy industry. As we demonstrate below, nine out of ten ...
Friday, August 14, 2020

Using Technology to Improve Medication Access and Impact More Patients

›
Today’s guest post comes from Julia Phillips, VP of Pharma Accounts and Enablement at CoverMyMeds. Julia discusses the challenges of both ...
Tuesday, August 11, 2020

Five Top Drugmakers Reveal List vs. Net Price Gaps (Plus: The Trouble With Insulin Prices)

›
Time for our annual update on pricing at five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi. Y...
Friday, August 07, 2020

Patient Assistance Programs–Weathering COVID-19 and the Unknown

›
Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient ...
Tuesday, August 04, 2020

The Gross-to-Net Bubble Hit $175 Billion in 2019: Why Patients Need Rebate Reform

›
Last Friday’s Executive Orders  revived the government’s effort to reform rebates in federal programs. Whether that effort succeeds, today...
Monday, August 03, 2020

NASP 2020 Annual Meeting & Expo Virtual Experience

›
NASP 2020 Annual Meeting & Expo Virtual Experience September 14-18, 2020 | Virtual Experience www.naspmeeting.com/registration Uti...